All sessions are noted in Eastern Time Zone. Please adjust to your time zone accordingly
Program Schedule * April 24-26, 2024
The art of safe prescribing begins with understanding the importance of a medication's pharmacokinetic (PK) and pharmacodynamic profile. This program highlights the importance of the drug's pharmacokinetic profile, including absorption, distribution, elimination, drug bioavailability, biotransformation, T ½, clearance, steady state, Tmax, and AUC, on the selection of a medication. The importance of a medication's pharmacodynamic profile on disease management is highlighted.
Learning Outcomes/Objectives
Credits: CE credits: 1.5; Rx credits: 1.5
In this interactive experience, you will explore the clinical profile, efficacy, and safety of a once-daily GLP-1 RA treatment for adults with T2D on your own phone or device. Lead your team to victory as you collect data blocks to
evaluate mean change in glycated hemoglobin (A1C) results from a monotherapy trial in adult patients with T2D and
evaluate proper administration and storage instructions. Finally, review dosing instructions to better understand scenarios for your appropriate adult patients with type 2 diabetes.
Since 2015, more data has been published surrounding GLP-1 agonists and their potential benefits for patients with and without diabetes. There are studies showing that these agents can cause significant weight loss, improve cardiovascular outcomes, have positive renal effects, and even lower the risk of stroke. It is important for nurse practitioners to be educated on these drugs as their popularity and use increases in practice.
Credits: CE 1.5; Rx 1.5
Hot off the press! New international guidelines are available for identifying and staging CKD patients in your practice. More than 1 in 7 US adults (35.5 million people), or 14%, already have CKD. The scarier part is that 9 in 10 adults who have it don't know that they do! Join this session to find out all the newest guideline-directed treatments that can slow progression of CKD. We now know that we as providers can make a difference, but only if we identify these patients and intervene early. One in 3 of your patients is at risk for CKD; do you know who they are?
Credits: CE 1.5; Rx 1
About 1.9 million brain cells die every minute while a stroke goes untreated, making stroke treatment algorithms critical to shaving off time to treatment to save lives. Attendees will be taken on a compelling journey empowering them to develop timely, efficient, and effective stroke treatment algorithms to reduce time to diagnosis and treatment in service of improving outcomes.
Credits: CE: 1.5; Rx: 1.5
Pre-exposure prophylaxis (PrEP) is therapy that is 92% to 99% effective in preventing HIV and is an important primary care strategy to end the HIV epidemic. Many NPs are not familiar or comfortable with prescribing PrEP when it is requested by a patient or indicated by the patient's sexual history. The purpose of this session is to illuminate the role of the NP in prescribing PrEP to patients. This session provides an opportunity for practicing clinicians to improve their knowledge and skills related to the provision of PrEP and non-occupational post-exposure prophylaxis (nPEP). A case study approach is used to meet the educational objectives.
Pharmacotherapy is often the central intervention used to improve symptoms or delay the progression of dementia syndromes. The available agents vary with respect to their therapeutic actions and their level of evidence-based support for efficacy. This session will review various medications, their mechanisms of action, and their effect on behavior and health. Join as well for a discussion about when it is best to refer your patients.
We are hearing more about infectious diseases than ever before; as NPs, we are expected to have answers for our families and our patients. What are the risk factors for contracting these infectious diseases? How can you protect yourself, your loved ones, and your patients from these threats? Learn the latest information and treatment options in this important session.
Credits: CE credits: 1.5; Rx credit: 1
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease with a worldwide prevalence of 32%. It is increasing at an alarming pace and is becoming the number one reason for liver transplantation. Please join us for a case-based, practical, very interactive, and fun seminar through which you will acquire the clinical tools needed to diagnose and treat your patients with NAFLD.
Credits: CE 1.5; Rx 0.5
Explore the dynamic intersection of nutrition and systemic health in this course. Delve into the core concepts of the nutrition-health connection, where cutting-edge research has uncovered crucial nutrients for health promotion. Investigate how cultivating a healthy diet through food synergy and diet diversity can enhance immune health. Gain insights into the latest scientific findings regarding the profound impact of whole foods on health, equipping you with effective communication tools for both patients and clients. This course will bridge the gap between nutrition research and practical applications, empowering NPs to promote positive nutritional and systemic health outcomes.
Credits: CE 1.5
Invasive fungal infections are responsible for around 1.5 million global deaths each year and pose unique diagnostic challenges for clinicians. Patient survival often hinges on early identification and initiation of antifungal treatment. This session will focus on how to identify host risk factors that place patients at risk for invasive fungal infections. The common presentations of and treatment for several fungal infections will be covered along with a discussion of the growing world of antifungal therapy.
Credits: CE: 1.5; Rx 1
